Release-profile design
A format-specific objective that must be confirmed through analytical and product development.
Delivery technology
Controlled-Release Tablets
Layered or matrix tablets designed for stable, extended oral exposure.
Why it matters
Longer exposure is useful only when release, stability and pharmacokinetic assumptions are validated.
Layered or matrix tablets designed for stable, extended oral exposure.
Availability, specifications and regulatory status vary by market, formulation and stage of development.
- Scientific rationale is distinguished from demonstrated outcomes.
- Capabilities are mapped to application, format and regulatory context.
- Confidential depth is available through qualified access rather than exposed publicly.
Designed as a platform
What makes this approach different
ChronoSense® connects the biological hypothesis to delivery, evidence, data and a controlled route to market.
Once- or twice-daily convenience concepts
Designed around user context without substituting convenience for evidence.
Scalable oral manufacturing
Integrated with quality, manufacturing and claims planning from the start.
A disciplined pathway
From insight to accountable action
The platform is designed to move through explicit stages, with evidence and access appropriate to each one.
1
Opportunity definition
Specify dose range, application, use time, territory and desired exposure.
2
Formulation feasibility
Evaluate material compatibility, stability and release or uptake behavior.
3
Validation
Establish specifications, safety and fit-for-purpose evidence.
4
Commercial transfer
Connect documentation, manufacturing, supply and licensing terms.
Next step
Discuss a controlled-release tablets program.
Share your application, market, timing and evidence needs so the right technical pathway can be assessed.